Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Xavier University of Louisiana College of Pharmacy Curriculum Map – NAPLEX Competencies Map by Competency 1 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.1 – Identify and assess patient information including medication, laboratory and disease state histories. Course CBCO Teaching method(s) Assessment method(s) DSM - I I L T Biopharmaceutics I L HW, T Pharmacy Practice E CS Lab DSM – II R, E L, VT, CS, O T, IGP IPPE – III R SGD, O OP, IGP Clinical Rotation R, E SGD, O, CS OP, IGP, T, Q, D, O 2 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.2 – Identify and/or use instruments and techniques related to patient assessment and diagnosis. Course CBCO Teaching method(s) Assessment method(s) Pathophysiology I L, CS T DSM – I I L T Pharmacy Practice E VT, CS, GS OP, IGP, Lab, D DSM – II R L ? DSM – III I, E L, CS T, IGP 3 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.2 – Identify and/or use instruments and techniques related to patient assessment and diagnosis. Course CBCO Teaching method(s) Assessment method(s) IPPE – III E SGD, O OP Clinical Rotation R, E SGD, OP, O, CS OP, IGP, Q, D 4 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.3 – Identify and define the terminology, signs and symptoms associated with diseases and medical conditions. Course CBCO Teaching method(s) Assessment method(s) Biochemistry I L T Med. Chem. I I L T Pathophysiology I CS, L T DSM – I I L T Med. Chem. II R L T 5 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.3 – Identify and define the terminology, signs and symptoms associated with diseases and medical conditions. Course CBCO Teaching method(s) Assessment method(s) DSM – II R L T DSM – III I, E L, CS, O T, IGP IPPE – III E SGD, O IGP, OP Clinical Rotation R SGD, CS, O OP, IGP, O 6 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.4 – Identify and evaluate patient factors, genetic factors, biosocial factors, and concurrent drug therapy that are relevant to the maintenance of wellness and the prevention or treatment of a disease or medical condition. Course CBCO Teaching method(s) Assessment method(s) Med. Chem. I I L T DSM – I I L T Biopharmaceutics I L HW, T Pharmacy Practice E CS Lab 7 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.1.0 – Obtain, interpret and evaluate patient information to determine the presence of a disease or medical condition, assess the need for treatment and/or referral, and identify patient-specific factors that effect health, pharmacotherapy, and/or disease management 1.1.4 – Identify and evaluate patient factors, genetic factors, biosocial factors, and concurrent drug therapy that are relevant to the maintenance of wellness and the prevention or treatment of a disease or medical condition. Course CBCO Teaching method(s) Assessment method(s) DSM – II R L T DSM – III I, E L, VT, CS, O T, IGP IPPE – III R SGD O,OP, IGP Clinical Rotation I, R, E SGD, CS, O OP, Q, IGP, O 8 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.1 – Identify specific uses and indications for drug products. Course CBCO Teaching method(s) Assessment method(s) Biochemistry I L T Pharmaceutics I ? ? Med. Chem. I I L T DSM – I I L T Med. Chem. II I L T Biopharmaceutics R L HW, T 9 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.1 – Identify specific uses and indications for drug products. Course CBCO Teaching method(s) Assessment method(s) Pharmacy Practice E CS Q, OP, IGP, Lab DSM – II R L T DSM – III R, E L, CS, O T, IGP IPPE – III R SGD IGP, OP Clinical Rotation R, E SGD, CS, O T, Q, OP, HW, IGP, D 10 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.2 – Identify the known or postulated sites and mechanisms of action of pharmacotherapeutic agents. Course CBCO Teaching method(s) Assessment method(s) Principles of Drug Action I L T, Q Med. Chem. I I L T P. Sciences Lab I, R L IGP, Lab, D, T DSM – I R L T Med. Chem. II I L T 11 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.2 – Identify the known or postulated sites and mechanisms of action of pharmacotherapeutic agents. Course CBCO Teaching method(s) Assessment method(s) Pharmacy Practice E CS Q, OP, IGP, Lab DSM – II R L T DSM – III R, E L, VT, CS, O T, IGP IPPE – III R SGD, O OP, IGP Clinical Rotation R, E CS, SGD, O Q, T, OP, D 12 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.3 –Evaluate drug therapy for the presence of pharmacotherapeutic duplications and interactions with other drugs, food, diagnostic tests, and monitoring procedures. Course CBCO Teaching method(s) Assessment method(s) Med. Chem. I I L T DSM – I I CS ? Pharmacy Practice E CS OP, HW, IGP, Lab DSM – II R L T DSM – III I, E L, CS T, IGP 13 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.3 –Evaluate drug therapy for the presence of pharmacotherapeutic duplications and interactions with other drugs, food, diagnostic tests, and monitoring procedures. Course CBCO Teaching method(s) Assessment method(s) IPPE – III R SGD, O OP, IGP Clinical Rotation R, E CS, SGD, O Q, RP, P, OP, D 14 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.4 –Identify contraindications, warnings, and precautions associated with a drug product’s active and inactive ingredients. Course CBCO Teaching method(s) Assessment method(s) Principles of Drug Action I L T, Q, RP Med. Chem. I I L T DSM – I I L, CS T Med. Chem. II I L T Pharmacy Practice E CS Q, RP, OP, IGP, Lab 15 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.4 –Identify contraindications, warnings, and precautions associated with a drug product’s active and inactive ingredients. Course CBCO Teaching method(s) Assessment method(s) DSM – II R L T DSM – III R, E L, CS T, IGP IPPE – III R SGD, O IGP, OP Clinical Rotation R, E SGD, CS, O Q, OP, IGP, D 16 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.5 –Identify physiochemical properties of drug substances that affect their solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic actions and stability. Course CBCO Teaching method(s) Assessment method(s) Principles of Drug Action I L T, Q, RP Pharmaceutics I I L Lab, T Med. Chem. I I, R L T P. Sciences Lab R L D, Lab, IGP Med. Chem. II I, R L T 17 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.5 –Identify physiochemical properties of drug substances that affect their solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic actions and stability. Course CBCO Teaching method(s) Assessment method(s) Biopharmaceutics R L T Pharmacy Practice R CS Lab DSM – II R L T Applied Kinetics I L T DSM – III E CS IGP 18 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.5 –Identify physiochemical properties of drug substances that affect their solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic actions and stability. Course CBCO Teaching method(s) Assessment method(s) IPPE – III R SGD, O OP Clinical Rotation R, E CS,SGD, O Q, D 19 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.6 – Interpret and apply pharmacodynamic and pharmacokinetic principles to calculate and determine appropriate drug dosing regimens. Course CBCO Teaching method(s) Assessment method(s) Principles of Drug Action I L RP, T, Q P. Sciences Lab R L IGP, Lab, D Biopharmaceutics I L T, HW, D Pharmacy Practice E L, CS T, Lab DSM – II R L T 20 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.6 – Interpret and apply pharmacodynamic and pharmacokinetic principles to calculate and determine appropriate drug dosing regimens. Course CBCO Teaching method(s) Assessment method(s) Applied Kinetics I L T DSM – III I, E L, CS T, IGP IPPE – III R O, SGD IGP, OP Clinical Rotation R, E SGD, CS, O Q, OP, D 21 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.7 – Interpret and apply biopharmaceutic principles and the pharmaceutical characteristics of drug dosage forms and delivery systems, to assure bioavailability and enhance patient compliance. Course CBCO Teaching method(s) Assessment method(s) Principles of Drug Action I L T, Q, RP Pharmaceutics I I, R L T, Lab Biopharmaceutics I L HW, T Pharmacy Practice E VT, CS, GS OP, IGP, Lab DSM – II R L T 22 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.2.0 – Identify, evaluate, and communicate to the patient or health-care provider, the appropriateness of the patient’s specific pharmacotherapeutic agents, dosing regimens, dosage forms, routes of administration, and delivery systems. 1.2.7 – Interpret and apply biopharmaceutic principles and the pharmaceutical characteristics of drug dosage forms and delivery systems, to assure bioavailability and enhance patient compliance. Course CBCO Teaching method(s) Assessment method(s) Applied Kinetics R L T DSM – III E CS IGP IPPE – III R SGD OP Clinical Rotation R, E SGD, CS, O Q, OP, D 23 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.1 – Identify pharmacotherapeutic outcomes and endpoints. Course CBCO Teaching method(s) Assessment method(s) DSM – I I L T Med. Chem. II ? L T Pharmacy Practice R CS IGP, Lab DSM – II R L T DSM – III I, E CS, L T, IGP 24 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.1 – Identify pharmacotherapeutic outcomes and endpoints. Course CBCO Teaching method(s) Assessment method(s) IPPE – III R SGD OP Clinical Rotation R, E SGD, O Q, OP, D 25 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.2 – Evaluate patient signs and symptoms, and the results of monitoring tests and procedures to determine the safety and effectiveness of pharmacotherapy. Course CBCO Teaching method(s) Assessment method(s) DSM – I I L, CS T DSM – II R L T DSM – III I, E L, CS T, IGP IPPE – III R SGD, O OP, IGP Clinical Rotation R, E SGD, O OP, T, Q, D 26 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.3 – Identify, describe the mechanism of, and remedy adverse reactions, allergies, side effects and iatrogenic or drug-induced illness. Course CBCO Teaching method(s) Assessment method(s) Biochemistry I L T Med. Chem. I I L T Med. Chem. II I L T Pharmacy Practice R CS Lab DSM – II R L T 27 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.3 – Identify, describe the mechanism of, and remedy adverse reactions, allergies, side effects and iatrogenic or drug-induced illness. Course CBCO Teaching method(s) Assessment method(s) DSM – III I, E L, CS IGP IPPE – III R O, SGD OP Clinical Rotation R, E SGD, CS, O RP, OP, D 28 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.4 – Prevent, recognize, and remedy medication non-adherence, misuse or abuse. Course CBCO Teaching method(s) Assessment method(s) DSM – I I L T Pharmacy Practice E CS IGP, Lab DSM – II R L T DSM – III I, E L, CS IGP IPPE – III I O, SGD OP, RP Clinical Rotation R, E SGD, O OP, D 29 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.5 – Recommend pharmacotherapeutic alternatives. Course CBCO Teaching method(s) Assessment method(s) Med. Chem. I I L T DSM – I I L, CS T Med. Chem. II I L T DSM – II R L T 30 Area 1 - Assure Safe and Effective Pharmacotherapy and Optimize Therapeutic Outcomes 1.3.0 –Manage the drug regimen by monitoring and assessing the patient and/or patient information, collaborating with other health care professionals, and providing patient education. 1.3.5 – Recommend pharmacotherapeutic alternatives. Course CBCO Teaching method(s) Assessment method(s) DSM – III I, E L, CS T, IGP IPPE – III R SGD, O OP, IGP Clinical Rotation R, E SGD, O OP, T, Q, IGP, D 31 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.1.0 – Perform calculations required to compound, dispense, and administer medication. 2.1.1 – Calculate the quantity of medication to be compounded or dispensed; reduced and enlarge formulation quantities and calculate the quantity of ingredients needed to compound the proper amount of the preparation. Course CBCO Teaching method(s) Assessment method(s) Pharmaceutics I R L Lab, T Pharmacy Practice E L Lab IPPE – III I SGD ? 32 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.1.0 – Perform calculations required to compound, dispense, and administer medication. 2.1.2 – Calculate nutritional needs and the caloric content of nutrient sources. Course CBCO Teaching method(s) Assessment method(s) Pharmacy Practice E CS Lab 33 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.1.0 – Perform calculations required to compound, dispense, and administer medication. 2.1.3 – Calculate the rate of drug administration. Course CBCO Teaching method(s) Assessment method(s) Biopharmaceutics I L T, Q, HW Pharmacy Practice E CS Lab DSM – II R L T Applied Kinetics R L T 34 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.1.0 – Perform calculations required to compound, dispense, and administer medication. 2.1.4 – Calculate or convert drug concentrations, ratio strengths, and/or extent of ionization. Course CBCO Teaching method(s) Assessment method(s) Pharmaceutics I I, R L T, Lab Biopharmaceutics R L T, HW Pharmacy Practice E L, CS Lab Applied Kinetics R L T 35 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.1 – Identify drug products by their generic, brand, and/or common names. Course CBCO Teaching method(s) Assessment method(s) Med. Chem. I I L T DSM – I R L T Med. Chem. II I L T Pharmacy Practice E O Q DSM – II R L T 36 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.1 – Identify drug products by their generic, brand, and/or common names. Course CBCO Teaching method(s) Assessment method(s) DSM – III R L T Pharmacy Law R L T IPPE – III R SGD OP Clinical Rotation R, E SGD, O T, Q, OP, IGP, O 37 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.2 – Determine whether a particular drug dosage strength or dosage form is commercially available, and whether it is available on a nonprescription basis. Course CBCO Teaching method(s) Assessment method(s) DSM - I I L ? Pharmacy Practice E O Q DSM – II R L T DSM – III R L ? 38 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.2 – Determine whether a particular drug dosage strength or dosage form is commercially available, and whether it is available on a nonprescription basis. Course CBCO Teaching method(s) Assessment method(s) Pharmacy Law R L T IPPE - III R SGD OP Clinical Rotation I, E SGD, O OP, HW, O 39 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.3 – Identify commercially available drug products by their characteristic physical attributes. Course CBCO Teaching method(s) Assessment method(s) Clinical Rotation E SGD, O OP, O 40 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.4– Interpret and apply pharmacokinetic parameters and quality assurance data to determine equivalence among manufactured drug products, and identify products for which documented evidence of inequivalence exists. Course CBCO Teaching method(s) Assessment method(s) Biopharmaceutics I L T, HW Applied Kinetics R L T IPPE – III R SGD ? Clinical Rotation E O O 41 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.5 – Identify and communicate appropriate information regarding packaging, storage, handling, administration, and disposal of medications. Course CBCO Teaching method(s) Assessment method(s) Principles of Drug Action I L RP, Q, T DSM – I I L ? Biopharmaceutics R L T, HW Pharmacy Practice E O Q 42 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.5 – Identify and communicate appropriate information regarding packaging, storage, handling, administration, and disposal of medications. Course CBCO Teaching method(s) Assessment method(s) Pharmacy Law E L T IPPE – III I SGD ? Clinical Rotation I, E SGD,O OP, D, O 43 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.2.0 – Select and dispense medications in a manner that promotes safe and effective use. 2.2.6 – Identify and describe the use of equipment and apparatus required to administer medications. Course CBCO Teaching method(s) Assessment method(s) Calculations I L T, Q, HW DSM – I I L ? Pharmacy Practice E CS Q, OP, IGP, D, O Applied Kinetics I L T IPPE – III I SGD O Clinical Rotation E SGD, O O 44 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.3.0 – Prepare and compound extemporaneous preparations and sterile products. 2.3.1 – Identify and describe techniques and procedures related to drug preparation, compounding and quality assurance. Course CBCO Teaching method(s) Assessment method(s) Pharmaceutics I E L T, Lab Rsch. & Lit. Eval. I E L T, RP Pharmacy Law R L T IPPE – III I GS ? 45 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.3.0 – Prepare and compound extemporaneous preparations and sterile products. 2.3.2 – Identify and use equipment necessary to prepare and extemporaneously compound medications. Course CBCO Teaching method(s) Assessment method(s) Calculations I L HW, T, Q Pharmaceutics I E L T, Lab IPPE – III I GS ? 46 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.3.0 – Prepare and compound extemporaneous preparations and sterile products. 2.3.3 – Identify the important physiochemical properties of a preparation’s active and inactive ingredients; describe the mechanism of, and the characteristic evidence of incompatibility or degradation; and identify methods for achieving stabilization of the preparation Course CBCO Teaching method(s) Assessment method(s) Biochemistry I L T Principles of Drug Action I L T, Q,RP Pharmaceutics I I, R L T, Lab Med. Chem. I I, R L T 47 Area 2 - Assure Safe and Accurate Preparation and Dispensing of Medications 2.3.0 – Prepare and compound extemporaneous preparations and sterile products. 2.3.3 – Identify the important physiochemical properties of a preparation’s active and inactive ingredients; describe the mechanism of, and the characteristic evidence of incompatibility or degradation; and identify methods for achieving stabilization of the preparation Course CBCO Teaching method(s) Assessment method(s) P. Sciences Lab R L D, Lab, IGP Med. Chem. II I L T IPPE – III I GS ? 48 Area 3 - Provide Health Care Information and Promote Public Health 3.1.0 – Access, evaluate, and apply information to promote optimal health care. 3.1.1 – Identify the typical content and organization of specific sources of drug and health information for both health care providers and consumers. Course CBCO Teaching method(s) Assessment method(s) PSL – I I L, SGD, O RP, P, OP, HW, IGP IPPE – III I SGD IGP Clinical Rotation I, R, E O, SGD OP, O 49 Area 3 - Provide Health Care Information and Promote Public Health 3.1.0 – Access, evaluate, and apply information to promote optimal health care. 3.1.2 – Evaluate the suitability, accuracy, and reliability of information from reference sources by explaining and evaluating the adequacy of experimental design and by applying and evaluating statistical test and parameters. Course CBCO Teaching method(s) Assessment method(s) PSL – I I O, SGD, L IGP, HW, OP, P, RP Biopharmaceutics R L T IPPE – III I SGD RP, OP, IGP Clinical Rotation R, E O, CS, SGD O, OP 50 Area 3 - Provide Health Care Information and Promote Public Health 3.2.0 – Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.1 – Provide health care information regarding the prevention and treatment of diseases and medical conditions, including emergency patient care. Course CBCO Teaching method(s) Assessment method(s) Pharmacy Law R L T IPPE – III I SGD IGP Clinical Rotation R, E O, SGD D, HW, OP 51 Area 3 - Provide Health Care Information and Promote Public Health 3.2.0 – Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.2 – Provide health care information regarding nutrition, lifestyle, and other non-drug measures that are effective in promoting health or preventing or minimizing the progression of a disease or medical condition. Course CBCO Teaching method(s) Assessment method(s) Biochemistry I L T Pharmacy Practice R CS OP, IGP Pharmacy Law R L T IPPE – III I SGD ? Clinical Rotation R, E SGD, O OP, D 52 Area 3 - Provide Health Care Information and Promote Public Health 3.2.0 – Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.3 – Provide information regarding the documented uses, adverse effects and toxicities of dietary supplements. Course CBCO Teaching method(s) Assessment method(s) Pharmacy Practice E CS RP, OP, IGP Pharmacy Law R L T IPPE – III I SGD ? Clinical Rotation R, E SGD, CS, O OP, IGP, D 53 Area 3 - Provide Health Care Information and Promote Public Health 3.2.0 – Educate the public and health care professionals regarding medical conditions, wellness, dietary supplements, and medical devices. 3.2.4 – Provide information regarding the selection, use and care of medical/surgical appliances and devices, self-care products, and durable medical equipment, as well as products and techniques for self-monitoring of health status and medical conditions. Course CBCO Teaching method(s) Assessment method(s) Pharmacy Law R L T Clinical Rotation R, E SGD, O OP, D 54